MedPath

MOTRIN 300MG

MOTRIN 300MG

Approved
DIN Number

02242632

Drug Class

Human

Market Date

May 15, 2002

Company
HC

mcneil consumer healthcare division of johnson & johnson inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02242632
AIG Number0108883001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
M01AE01 IBUPROFEN
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification28:08.04.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

IBUPROFENActive
Strength: 300 MG
Monograph: IBUPROFEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.